Condensation of acetylferrocene with 5-phenyl(4-methylphenyl)-1,2-oxazole-3-carbaldehydes afforded (Е)-3-[5-phenyl(4-methylphenyl)-1,2-oxazol-3-yl]-1-ferrocenylprop-2-en-1-ones. Reactions of (Е)-3-[5-(4-methylphenyl)-1,2-oxazol-3-yl]-1-ferrocenylprop-2-en-1-one with semicarbazide, thiosemicarbazide, and hydroxylamine led to the formation of 5-[5-(4-methylphenyl)-1,2-oxazol-3-yl]-3-ferrocenyl-4,5-dihydro-1Hpyrazole-1-carboxamide, 5-[5-(4-methylphenyl)-1,2-oxazol-3-yl]-3-ferrocenyl-4,5-dihydro-1H-pyrazole-1carbothioamide, and 5-(4-methylphenyl)-3'-ferrocenyl-4',5'-dihydro-3,5'-bi-1,2-oxazole respectively. Reactions of (Е)-3-[5-(4-methylphenyl)-1,2-oxazol-3-yl]-1-ferrocenylprop-2-en-1-one with guanidine and thiourea result in 4-[5-(4-methyl-phenyl)-1,2-oxazol-3-yl]-6-ferrocenylpyrimidin-2-amine and -2-thione respectively.Ferrocene derivatives incorporating in the molecule nitrogen heterocycles, in particular, ferrocenylalkylazoles, exhibit an antitumor activity combined with a low toxicity thus promoting the interest to the synthesis of their new specimens [1-3].We prepared ferrocene derivatives having several N-heterocycles in the a molecule, among them those with 1,2-oxazole. Some functionally substituted isoxazoles alongside with the antitumor action are capable of producing a synergetic effect in compositions with cytostatics used in the tumor chemotherapy thus considerably reducing the dose of the latter and the toxicity for the patient [4][5][6][7][8].The building up of heterocyclic systems is often performed with the use of α,β-unsaturated ketones [9, 10]. Therefore we first obtained 3-[5-phenyl-(4methylphenyl)-1,2-oxazol-3-yl]-1-ferrocenylprop-2-en-1-ones 1 and 2 by condensation of acetylferrocene 3